2022
Effectiveness and Tolerability of Brivaracetam by Reason for Initiation in Adults with Focal Seizures: Post-hoc Analysis of a Real-world, US Study (P15-8.003)
Henninger H, Sperling M, Altalib H, Dave H, Gelfand M, Porter R, Martin M, Elmoufti S, Schulz A, Dongre P, French J. Effectiveness and Tolerability of Brivaracetam by Reason for Initiation in Adults with Focal Seizures: Post-hoc Analysis of a Real-world, US Study (P15-8.003). Neurology 2022, 98 DOI: 10.1212/wnl.98.18_supplement.1443.Peer-Reviewed Original Research
2020
Psychiatric Adverse Events According to Psychiatric History and Current Status: A Post-hoc Analysis of Three Phase III Trials of Adjunctive Eslicarbazepine Acetate in Adults with Focal Seizures (4140)
Altalib H, Grinnell T, Cantu D, Ikedo F, Vieira M, Tosiello R, Blum D. Psychiatric Adverse Events According to Psychiatric History and Current Status: A Post-hoc Analysis of Three Phase III Trials of Adjunctive Eslicarbazepine Acetate in Adults with Focal Seizures (4140). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.4140.Peer-Reviewed Original Research